Related Experiment Video
Updated: Aug 18, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Antitumour quinones
1LEDSS, UMR CNRS 5616, Université Joseph Fourier, BP 53, 38041 Grenoble Cédex 9, France. christian.asche@ujf-grenoble.fr
Abstract:
Quinones still comprise one of the largest classes of antitumour agents. For example, the anthracycline antibiotics are among the most utilised anticancer agents ever developed. Many other quinones were tested for their anticancer activity. Though there are general and well-established mechanisms for quinone toxicity, the exact contribution of the quinone moiety to the cytotoxic effect remains frequently uncertain. However, DNA represents the main target for quinoid antitumour agents and most of them belong to the groups of DNA intercalating and/or alkylating agents. But also other cellular structures such as heat shock protein 90 or telomerase have been identified as targets for quinoid compounds.
Insights
Quinone compounds are significant anticancer agents, with DNA as their primary target through intercalation or alkylation. While their exact cytotoxic mechanisms are still explored, other cellular targets like heat shock protein 90 are also identified.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Biology
Background:
- Quinones represent a major class of anticancer drugs, including widely used anthracycline antibiotics.
- Despite their importance, the precise mechanisms underlying quinone-induced cytotoxicity are not fully elucidated.
- Research continues to explore the diverse biological activities of quinoid compounds.
Purpose of the Study:
- To review the role of quinones as antitumour agents.
- To discuss the known and uncertain mechanisms of quinone cytotoxicity.
- To highlight the primary molecular targets of quinoid anticancer compounds.
Main Methods:
- Literature review of quinone antitumour agents.
- Analysis of established mechanisms of quinone toxicity.
- Identification of key cellular targets, including DNA, heat shock protein 90, and telomerase.
Main Results:
- DNA is the principal target for most quinoid anticancer agents, acting via intercalation and/or alkylation.
- The exact contribution of the quinone structure to the overall cytotoxic effect often remains unclear.
- Emerging evidence points to other cellular targets, such as heat shock protein 90 and telomerase.
Conclusions:
- Quinones remain a vital class of antitumour agents with diverse mechanisms of action.
- Further research is needed to fully understand the structure-activity relationships and precise cytotoxic pathways.
- Identifying novel cellular targets will expand the therapeutic potential of quinoid compounds in cancer treatment.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Antiviral Nucleoside Inhibitors
